Clinical Trial Update: The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome

View source ↗

Summary

A completed clinical trial evaluated inhaled iloprost for Eisenmenger syndrome in patients with congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eisenmenger Syndrome

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Eisenmenger's Syndrome | Status: COMPLETED